sglt2 inhibitors and glp-1 receptor agonists Combining in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique SGLT2 Inhibitors and GLP-1 Receptor
Description
Persistent metabolic adaptation 6 years after The Biggest Loser competition
Analysis of six studies indicated a significantly higher incidence of nausea in GLP-1RAs group compared to the placebo group, with an odds ratio (OR) of 2.01 (95% CI 1.24 to 3.27) (Fig
Studies suggest it may support weight loss of around 1.5-2 kg (3-5 pounds) over 12-16 weeks
Kosowska A, Gallego-Colon E, Garczorz W, Klych-Ratuszny A, Aghdam MR, Woz Niak M, et al
